{
    "clinical_study": {
        "@rank": "144798", 
        "acronym": "NUTRIMOUV", 
        "arm_group": [
            {
                "arm_group_label": "Rehabilitation effort", 
                "arm_group_type": "Experimental", 
                "description": "custom work endurance combining dietary management adapted to the nutritional status and an APA. Included patients benefit from support for 19 weeks from the start of treatment"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "Control with dietary management adapted to the nutritional status"
            }
        ], 
        "brief_summary": {
            "textblock": "Improvement exercise tolerance"
        }, 
        "brief_title": "Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Head and Neck Cancer", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "This study allows improved exercise tolerance in patients undergoing rehabilitation effort"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Tumor squamous cell head and neck (excluding nasopharynx) nonmetastatic including\n             cervical lymphadenopathy primitives\n\n          -  Patient to be treated with curative radiotherapy monofractionn\u00e9e for at least 6\n             weeks, with or without concurrent chemotherapy (including targeted therapies)\n\n          -  KPS \u2265 60\n\n        Exclusion Criteria:\n\n          -  Cancer of the nasopharynx\n\n          -  Metastatic Patient\n\n          -  Patients who received neoadjuvant chemotherapy or induction\n\n          -  Patient parenteral nutrition\n\n          -  Non-compliant Patient Treatment\n\n          -  Patient with a cons-indication to the achievement of an effort: clinical signs of\n             pulmonary arterial hypertension (PAH) uncontrolled heart failure, recent myocardial\n             infarction, arrhythmias, unstable angina.\n\n          -  Patient desaturation in the stress test\n\n          -  Patient already included in another clinical trial with an experimental molecule\n\n          -  Pacemaker or defibrillator or neurostimulator\n\n          -  Contraindications to treatment with standard radiotherapy with or without concurrent\n             chemotherapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02135185", 
            "org_study_id": "VA2011/43"
        }, 
        "intervention": [
            {
                "arm_group_label": "Rehabilitation effort", 
                "description": "Experimental:   Rehabilitation effort", 
                "intervention_name": "custom work endurance", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "dietary management adapted to the nutritional status", 
                "intervention_name": "dietary management adapted to the nutritional status", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "contact": {
                "email": "jean-pierre.bleuse@icm.unicancer.fr", 
                "last_name": "BLEUSE Jean-pierre", 
                "phone": "0033467613102"
            }, 
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "zip": "34298"
                }, 
                "name": "Institut r\u00e9gional du Cancer - Montpellier - Val d'Aurelle"
            }, 
            "investigator": {
                "last_name": "senesse pierre", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase II Study, Multicentric, Randomized Studying the Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent", 
        "overall_official": {
            "affiliation": "ICM", 
            "last_name": "Pierre SENESSE", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients increasing rate of at least 40% of their initial endurance time 3 months after the completion of radiotherapy", 
            "measure": "measurement of the increase of initial endurance", 
            "safety_issue": "No", 
            "time_frame": "up to 24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02135185"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Quality of life 3 months after the end of radiotherapy (QLQ C30 and SF 36)", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }, 
            {
                "description": "\"Performance status\" (Karnofsky) 3 months after the end of radiotherapy.", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }, 
            {
                "description": "Quantity of daily physical activity to 3 months after the end of radiotherapy (Actimeter).", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }, 
            {
                "description": "Decrease addiction to 3 months after the end of radiotherapy (Declarative).", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }, 
            {
                "description": "Rate of feasibility of the protocol.", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }, 
            {
                "description": "Identification of indicator (s) to monitor the APA.", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }, 
            {
                "description": "Evaluation of precariousness (EPICES).", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 months after the end of radiotherapy"
            }
        ], 
        "source": "Centre Val d'Aurelle - Paul Lamarque", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Val d'Aurelle - Paul Lamarque", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}